Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$752K Sell
4,752
-2,265
-32% -$265K 0.61% 36
2026
Q1
$844K Sell
7,017
-410
-6% -$47.3K 0.83% 27
2025
Q4
$782K Sell
7,427
-4,760
-39% -$447K 0.87% 25
2025
Q3
$1.02M Hold
12,187
0.96% 23
2025
Q2
$965K Buy
12,187
+3,034
+33% +$241K 0.92% 25
2025
Q1
$822K Buy
+9,153
New +$855K 1% 25

Other funds holding MRK

Curat Global's MRK Position: Q2 2026 in Review

Curat Global reduced its Merck (MRK) stake by 32% in Q2 2026, selling an estimated $265K and leaving 4,752 shares worth $752K. The position accounts for 0.61% of the portfolio, ranked #36.

Curat Global first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.02M in Q3 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Curat Global held 4,752 shares of Merck worth $752K as of Q2 2026.
  • Curat Global sold 2,265 Merck shares in Q2 2026, an estimated $265K.
  • Merck made up 0.61% of Curat Global's portfolio in Q2 2026, its #36 holding.
  • Curat Global first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • Curat Global's Merck position peaked at $1.02M in Q3 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.